1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" is currently closed and not accepting applications.
Advancing Genomic Medicine Research (R01 Clinical Trial Optional) is sponsored by National Human Genome Research Institute (NHGRI). This funding opportunity seeks proposals that stimulate innovation and advance understanding of when, where, and how best to implement the use and sharing of genomic information and technologies in clinical care.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Advancing Genomic Medicine Research (AGMR) NIH Websites Are Changing Get the Latest Updates and FAQs Funded Programs and Projects Advancing Genomic Medicine Research (AGMR) The AGMR program stimulates innovation and advance understanding of when, where and how best to implement the use of genomic information and technologies in clinical care.
Historically, NHGRI has largely funded genomic medicine research through multi-disciplinary consortia. The AGMR program expands NHGRI’s genomic medicine portfolio to include focused research projects that propose nimble, flexible approaches to problems in application or implementation of genomic medicine.
AGMR investigators participate in at least one annual meeting, allowing for independent but synergistic efforts among grantees and promoting rapid sharing of successful approaches and resulting data.
Margaret Graham Kemper Parker Timothy Wei-Wen Yu Boston Children's Hospital VIGOR: Virtual Genome Center for Infant Health Caitlin Gloeckner Allen Medical University of South Carolina Facilitating the Implementation of Population-wide Genomic Screening across Diverse Populations and Settings (FOCUS) Lisa Bastarache Douglas Ruderfer Vanderbilt University Medical Center Translating the Clinical Knowledge of Mendelian Diseases to Real-World EHR Data to Improve Identification of Undiagnosed Patients Hugo J.
Bellen Michael Francis Wangler Baylor College of Medicine Genomic Medicine and Gene Function Implementation for an Underserved Population Jonathan S.
Berg Laura Vogel Milko University of North Carolina at Chapel Hill Age-Based Genomic Screening in Newborns, Infants and Children: A Novel Paradigm in Public Health Genomics Sean David University of Chicago Integrative Analyses of Clinical Pharmacogenetic Data to Prevent Hospital Readmission in Real-World Health Systems across Metropolitan Chicagoland Julio David Duarte University of Florida Preemptive Pharmacogenetic Testing in Medically Underserved Populations Sarah Knerr University of Washington Applying Population Management Best Practices to Preventive Genomic Medicine Iftikhar Kullo Mayo Clinic Rochester Genomic Medicine for Individuals from East Africa (GEMINEA) Cong Liu Columbia University Health Sciences RESCUE: Rare Disease Detection and Escalation Support Via a Learning Health System Aimé Lumaka Zola Universite De Kinshasa African Rare Diseases Initiative (ARDI): Advancing Genomic Medicine through rare diseases research in Africa Gabor T.
Marth Martin Tristani-Firouzi University of Utah Calypso: A Web Software System Supporting Team-Based, Longitudinal Genomic Diagnostic Care Katherine L. Nathanson Robert A.
Schnoll University of Pennsylvania Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure Across a Diverse Health System Lori Ann Orlando Duke University Deploying a Genomic Medicine Risk Assessment Model for Diverse Primary Care Populations and Settings Joseph F. Peterson David L.
Veenstra Vanderbilt University Medical Center Rational Integration of Polygenic Risk Scores (RIPS) Kathryn A. Phillips University of California, San Francisco Building the Evidence Base for Appropriate and Efficient Implementation of Emerging Genomic Tests for Disease Management and Screening Marc S. Williams Geisinger Clinic Real-Time Genetic Diagnosis at the Point of Care **Eric A.
Boerwinkle GQ Zhang University of Texas Hlth Sci Ctr Houston Implementation Science for Genomic Health Translation (INSIGHT) **Renata Constance Gallagher University of California, San Francisco Toward DNA Sequencing as a Primary Newborn Screen for Treatable Disorders Not Amenable to Current Screening **Catherine Astrid Brownstein Boston Children's Hospital Navigating Online Patient Experiences of Genomic Medicine: Identifying and Overcoming Obstacles for African American Communities **Past Grantees More information about AGMR’s funded projects is available in NIH’s RePORTER .
RFA-HG-25-002 : Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Application Due Date(s): February 11, 2025 Expiration Date: February 12, 2025 RFA-HG-25-003 : Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Application Due Date(s): February 11, 2025 Expiration Date: February 12, 2025 RFA-HG-25-004 : Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed) Application Due Date(s): February 11, 2025 Expiration Date: February 12, 2025 RFA-HG-23-032 : Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025 Expiration Date: November 19, 2024 RFA-HG-23-033 : Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025 Expiration Date: November 19, 2024 RFA-HG-23-048 : Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed) Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025 Expiration Date: November 19, 2024 NOT-HG-24-002 : Notice of Special Interest (NOSI): Advancing Genomic Medicine Research through Small Businesses RFA-HG-20-036 : Advancing Genomic Medicine Research (Clinical Trial Optional) (R01) Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023 Expiration Date: March 14, 2023 NOT-HG-23-034 : Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R01 Clinical Trial Optional) RFA-HG-20-037 : Advancing Genomic Medicine Research (Clinical Trial Optional) (R21) Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023 Expiration Date: March 14, 2023 NOT-HG-23-035 : Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Christine Q.
Chang, M. P. H.
Division of Genomic Medicine Renee Rider, M. S. , J.
D. , LCGC Division of Genomic Medicine Scientific Program Analyst Division of Genomic Medicine Last updated: January 21, 2025
According to the current listing, eligibility includes: Nonprofit organizations, including universities and research institutions. Confirm the full requirements in the official notice before applying.
The published deadline was February 11, 2025, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Advancing Genomic Medicine Research (R01 Clinical Trial Optional) is funded by National Human Genome Research Institute (NHGRI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleWhile headlines chase AI and defense money, USDA's National Institute of Food and Agriculture runs a tight summer competitive cycle — Equipment Grants (June 25), Agricultural Genome to Phenome (June 29), New Beginning for Tribal Students (July 2), and Crop Protection and Pest Management (July 6). Here is how the four programs fit together, who is eligible, and why the land-grant system has a structural edge.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read article